l-carnitine half-life Pharmacokinetics of | Clinical Pharmacokinetics Frontiers | Carnitine Traffic in
Description
In many trials, the headache rate in treated participants does not exceed expected background rates, which argues against a strong causal effect across broad populations
A significant decrease in asparagine levels was also found
Al tiempo se han descrito diferentes teoras sobre su modo de accin
No clinical studies have evaluated antioxidant efficacy in biomarker-defined ASD groups, and standardized criteria for identifying such profiles remain lacking
